Microbiology & Pathology in New York

IMMCO Diagnostics is a clinical reference laboratory located in Buffalo, NY, specializing in serological and biopsy testing for autoimmune diseases and pregnancy-related complications. Licensed throughout the United States, the company offers diagnostic testing for Sjögren's syndrome, Rheumatoid Arthritis, Celiac Disease, Ulcerative Colitis, Crohn's Disease, Systemic Lupus Erythematosus, and Scleroderma. The laboratory is known for developing proprietary biomarkers, including novel SP-1, CA-6, and PSP markers for Sjögren's syndrome that increase diagnostic sensitivity above 80% before traditional antibodies appear. IMMCO also provides preeclampsia risk assessment testing using FDA-cleared biomarkers (sFlt-1 and PlGF) with KRYPTOR instrumentation to guide early clinical intervention and reduce maternal-fetal complications. The company was co-founded by periodontists and maintains specialized Oral and Maxillofacial pathology services with over 40 years' experience; staff includes board-certified oral and immune pathologists offering case consultations and second opinions. Services include individual tests, panels, genetic testing for autoimmune conditions, and family screening. The laboratory operates as a reference service provider, accepting specimens from healthcare providers nationwide.

Morphle Labs Inc. is an AI-enabled health tech company specializing in digital pathology and cancer diagnostics automation. The company develops robotic whole slide scanners, robotic microtomes, and intelligent image management systems designed to enhance pathology lab workflows. Their product portfolio addresses tissue preparation, high-throughput slide scanning, AI-driven image analysis, and digital archiving. The MorphoLens scanner family (240, 6, 1 variants) and HemoLens platform serve anatomical pathology, dermatopathology, hematology, and cytology applications. Morphle's solutions enable telepathology, reduce turnaround time, improve diagnostic accuracy, and support research institutions and cancer hospitals globally. The company holds 25+ patents and emphasizes superior image quality, LIS integration, and compact data storage formats.

KSL Diagnostics is a national reference laboratory headquartered outside Buffalo, New York, specializing in CLIA-certified and CAP-accredited cytogenetic diagnostic testing. The company focuses on comprehensive chromosome abnormality analysis for oncology and acquired genetic disorders, serving pathologists and clinicians across the United States. KSL Diagnostics operates a state-of-the-art facility with a team of highly qualified clinical professionals possessing over 75 years of combined clinical service experience. The organization employs a consultative approach to guide physicians through a comprehensive testing menu, supporting precision medicine initiatives and improved patient outcomes. Strategic partnerships, including affiliation with University at Buffalo and Thermo Fisher Scientific, enhance KSL's diagnostic capabilities and service offerings. The company's core competencies include cytogenetic analysis, chromosome disorder diagnosis, and reference laboratory services. Leadership is composed of industry experts committed to quality assurance, customer service, and solutions-driven laboratory operations. KSL Diagnostics operates under three guiding principles: Excellence, Innovation, and Growth.

Paige.AI is a clinical AI software company specializing in computational pathology for cancer diagnostics and biomarker discovery. The company develops AI-assisted diagnostic applications and foundation models for histopathology analysis, enabling pathologists to detect, subtype, and identify molecular biomarkers from tissue samples. Core product lines include the Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige PanCancer Suite—all designed to support cancer detection and classification on H&E-stained whole-slide images. The company licenses advanced foundation models (Virchow, Virchow2, Virchow2G, Virchow2G-Mini, and PRISM) to partners for custom AI development in cancer care. Paige Alba is a proprietary co-pilot platform integrating voice and text interfaces with AI diagnostics to streamline pathology workflows. The company provides comprehensive services including custom AI development, regulatory strategy consulting, and commercialization support. Paige's technology is trained cumulatively on over 1.5 million slides and designed to address diagnostic scalability and workload pressures in clinical pathology settings. The firm serves pharmaceutical, life sciences, research, and healthcare provider organizations globally.

ARX Sciences is a specialized manufacturer and distributor of in vitro diagnostic reagents and biologicals based in Buffalo, New York. The company manufactures coagulation controls, microbiological transport media, and markets validated antibodies and recombinant proteins for research and clinical diagnostics. ARX operates cGMP-certified, ISO 13485-compliant, FDA-registered manufacturing facilities offering custom formulation development, contract manufacturing with flexible lot sizes, and proprietary formulation support. Core product lines include primary and secondary antibodies for ELISA, Western blot, immunohistochemistry, immunoprecipitation, and immunofluorescence applications; recombinant proteins such as human growth hormone; and EUA-authorized viral and bacterial transport media for specimen collection and preservation. The company provides end-to-end transparency in custom manufacturing, rapid turnaround (4–8 weeks), and integrated quality testing for diagnostic assay development and production.